US-based Boston Scientific has completed the patient enrolment in the EVOLVE II clinical trial, designed to assess the safety and effectiveness of SYNERGY stent system and support the US Food and Drug Administration and Japanese regulatory ...
Tags: Clinical Trial, Medicine
US-based medical device company TherOx has successfully completed the patient enrollment in its multicenter investigational device exemption (IDE) pilot study to evaluate the second generation system that delivers supersaturated oxygen ...
HeartWare International has received the U.S. Food and Drug Administration (FDA) approval to enroll supplemental patient cohort for ENDURANCE, a pivotal destination therapy clinical study. HeartWare will enroll up to 286 patients ...
Respicardia, a US-based developer of implantable therapies, has announced the enrollment of the first patients in the pivotal trial to evaluate the remede system in patients with central sleep apnea (CSA). The Respicardia pivotal trial is ...
Tags: Respicardia, Patient Enrollment
Kinetic Concepts has launched its new V.A.C. VeraFlo large dressing for larger wounds and wounds requiring additional c. VeraFlo large dressing is designed for easy application of V.A.C. VeraFlo instillation therapy. With this ...
Tags: Kinetic, Dressing Product
Cerevast Therapeutics has initiated patient enrollment in the Phase III clinical trial to evaluate the use of its Clotbust ER ultrasonic headframe for the treatment of acute ischemic stroke. The Clotbust ER Phase III clinical study is ...
Tags: Cerevast Therapeutics
Medical technology company Kinetic Concepts (KCI) has initiated patient enrollment in a multi-center clinical study that will assess the advantages of negative pressure wound therapy (NPWT) with intermittent instillation therapy with a ...
Tags: Health, Medicine, Medical technology
Sanofi and Regeneron Pharmaceuticals have announced the commencement of patient enrollment in two Phase 3 rheumatoid arthritis (RA) trials, the COMPARE and ASCERTAIN trials, with Sarilumab. The first fully human monoclonal antibody ...
Cohera Medical, a developer of absorbable surgical adhesives and sealants, has obtained regulatory approval to commence human clinical trials on its single-part synthetic surgical sealant in Europe. Designed as an adjunct to standard ...
Tags: Cohera Medical, absorbable surgical adhesives, sealants
Medtronic has submitted its investigational device exemption (IDE) application to the FDA to initiate a study of its Symplicity renal denervation system for the treatment of uncontrolled hypertension in patients with systolic blood pressure ...
ReShape Medical has completed patient enrollment in a pivotal clinical trial of its ReShape Duo Intragastric Balloon device, designed for the treatment of obese. Using a standard endoscope, non-surgical weight loss device is placed in the ...
Tags: ReShape, weight loss device, Medical
Covidien has completed patient enrollment in its VISIBILITY and DURABILITY Iliac stent clinical study series. The prospective, multinational, multicenter studies, which have enrolled 150 patients from 23 centers in the US and Europe, are ...
Velomedix has completed enrollment of the first patient in Velocity clinical study of its rapid therapeutic hypothermia system for treating acute myocardial infarction (AMIs or heart attacks). Using a peritoneal-based approach, the ...
Tags: Velomedix, Velocity clinical study, rapid therapeutic hypothermia system
Medtronic has completed patient enrollment in controlled, multicenter, prospective IN.PACT SFA II clinical trial of its IN.PACT Admiral drug-eluting balloon device for treating patients with peripheral artery disease in the superficial ...
Tags: drug, Medtronic, eluting balloon study
CardioFocus will complete full patient enrollment in a US pivotal clinical trial of its HeartLight catheter ablation system in 2013. The 350 patient-based trial, which is evaluating and comparing the safety and efficacy of the company's ...